Pomerantz LLP

Please review this complaint. Click to Contact Us about joining this ACTION >>

Questions? Ask Us

Paysign, Inc.

We are investigating Paysign, Inc. (PAYS) (“Paysign” or the “Company”) for potential violations of the federal securities laws. 

On September 9, 2019, Paysign announced a revision to its revenue guidance for fiscal year 2019, advising investors that “[t]otal revenue is now expected to be in the range of $35.0 million to $37.0 million,” compared to the Company’s previous guidance of $38.0 million to $40.0 million.  Paysign stated that “[t]he revised guidance primarily reflects delays in onboarding of new plasma industry programs planned for the first and second quarters of 2019.”  On this news, Paysign’s stock price fell $2.57 per share, or 21.35%, to close at $9.47 per share on September 9, 2019.